These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 14903605)
21. COMPARATIVE EFFECTIVENESS OF ORGANIC NITRATES: AN OBJECTIVE STUDY IN MAN. WENDKOS MH Curr Ther Res Clin Exp; 1963 Sep; 5():484-90. PubMed ID: 14061831 [No Abstract] [Full Text] [Related]
22. Pentaerythritol tetranitrate and metabolites in rat plasma. Crew M; Melgar MD; Di Carlo FJ J Pharmacol Exp Ther; 1975 Jan; 192(1):218-223. PubMed ID: 1123725 [TBL] [Abstract][Full Text] [Related]
23. Spectrophotometric determination of pentaerythritol tetranitrate in tablets. Shingbal DM; Agni RM J Assoc Off Anal Chem; 1984; 67(6):1123-4. PubMed ID: 6520087 [TBL] [Abstract][Full Text] [Related]
24. ABSORPTION, DISTRIBUTION AND EXCRETION OF PENTAERYTHRITOL AND PENTAERYTHRITOL TETRANITRATE BY MICE. DICARLO FJ; HARTIGAN JM; COUTINHO CB; PHILLIPS GE Proc Soc Exp Biol Med; 1965 Feb; 118():311-5. PubMed ID: 14268608 [No Abstract] [Full Text] [Related]
25. [How is antianginal therapy with pentaerythritol tetranitrate executed?]. Schneider CA Dtsch Med Wochenschr; 2002 Nov; 127(46):2465. PubMed ID: 12432490 [No Abstract] [Full Text] [Related]
26. Study of a timed-release preparation of pentaerythritol tetranitrate. Siegel MB West Med Med J West; 1966 Aug; 7(8):218-21. PubMed ID: 5341140 [No Abstract] [Full Text] [Related]
27. Effects of oral pentaerythritol tetranitrate in cardiac failure and angina pectoris. Assessment by hemodynamic measurement and exercise capacity. Amsterdam EA; Lee G; Awan NA; Low R; Mason DT Nouv Presse Med; 1980 Sep; 9(34 Suppl):2443-6. PubMed ID: 7422533 [TBL] [Abstract][Full Text] [Related]
28. Effects of continued pentaerythritol tetranitrate administration on myocardial circulation and metabolism. BENDER AD; SULLIVAN FJ; HORVATH SM Experientia; 1963 May; 19():254-6. PubMed ID: 13967330 [No Abstract] [Full Text] [Related]
29. [Letter: Loss of efficacy in long-term nitrites?]. Bleifeld W Dtsch Med Wochenschr; 1973 Oct; 98(40):1885. PubMed ID: 4762052 [No Abstract] [Full Text] [Related]
30. Therapeutic effects of pentaerythritol tetranitrate in the immediate postmyocardial-infarction period. Mellen HS; Goldberg HS; Friedman HF N Engl J Med; 1967 Feb; 276(6):319-22. PubMed ID: 6016292 [No Abstract] [Full Text] [Related]
31. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate]. Warembourg H; Théry C Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195 [No Abstract] [Full Text] [Related]
32. A study of the plasma levels of pentaerythritol mononitrate following administration of pentaerythritol tetranitrate in combination with meprobamate and diphenhydramine. Gilbert JD; Aylott RI; Draffan GH; Sögtrop HH Arzneimittelforschung; 1982; 32(5):571-4. PubMed ID: 7201836 [TBL] [Abstract][Full Text] [Related]
33. CONTINUOUS ELECTROCARDIOGRAPHIC RECORDING DURING EXERCISE: ITS USE IN EVALUATING THE EFFECT OF PENTAERYTHRITOL TETRANITRATE. KRASNO LR; KIDERA GJ Angiology; 1963 Aug; 14():417-25. PubMed ID: 14059280 [No Abstract] [Full Text] [Related]
34. ENZYMATIC DEGRADATION OF PENTAERYTHRITOL TETRANITRATE BY HUMAN BLOOD. DICARLO FJ; HARTIGAN JM; PHILLIPS GE Proc Soc Exp Biol Med; 1965 Feb; 118():514-6. PubMed ID: 14268670 [No Abstract] [Full Text] [Related]
35. Timed-release pentaerythritol tetranitrate and placebo in the management of angina pectoris. Cole RE; Goldberg RI Curr Ther Res Clin Exp; 1967 Nov; 9(11):551-7. PubMed ID: 4965503 [No Abstract] [Full Text] [Related]
36. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged]. Gatti A; Scotti G Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306 [No Abstract] [Full Text] [Related]